DexCom, headquartered in San Diego, develops glucose monitoring systems for diabetes management, employing 9,600 people since its IPO in 2005. Its products include the Dexcom G6 and G7 continuous glucose monitoring systems.
Dexcom (DXCM) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Dexcom's actual EPS was $0.48, beating the estimate of $0.45 per share, resulting in a 6.76% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
